- Moderna’s Shift to Cancer Company Lifts Stock Up 177% The New York Times —
- Skin cancer vaccine slashes risk of dying from the disease - giving hope to thousands Mirror —
- Moderna breakthrough: The options lottery tickets that paid out Seeking Alpha —
- Trump’s Moderna bet gets a double dose Seeking Alpha —
- Moderna nearly triples in record S&P 500 move, but analyst sees more volatility ahead Seeking Alpha —
- Moderna and Merck breakthrough could usher in wave of cancer vaccines TimesLIVE —
- Moderna’s experimental mRNA cancer treatment progresses, shares spike Global News —
- Breakthrough Personalized mRNA Vaccines Are Highly Effective Against Melanoma Skin Cancers Reason —
- Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally MarketWatch —
- Personalized mRNA-based cancer vaccine shows promise 📹 ABC News — · 2min
- Vaccine breakthrough stops cancer returning in trial BBC News —
- Moderna’s and Merck’s personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks soaring Fortune —
- Merck and Moderna say cancer vaccine shows signs of preventing recurrence of melanoma 📹 NBC News — · 2min
- Merck and Moderna say cancer vaccine shows signs of preventing recurrence of melanoma NBC News —
- Merck and Moderna say melanoma vaccine shows promise 📹 NBC News — · 24sec
- Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test CTV News —
- Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test Winnipeg Free Press —
- Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test The Independent —
- Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test The Philadelphia Inquirer —
- Moderna, Merck say cancer vaccine trial marks ‘landmark moment’ UPI —
RNA vaccine
Vaccine that transfects synthetic RNA, reprogramming cells to make foreign protein that stimulates an adaptive immune response
An mRNA vaccine is a type of vaccine that uses a copy of a molecule called messenger RNA (mRNA) to produce an immune response. The vaccine delivers molecules of antigen-encoding mRNA into cells, which use the designed mRNA as a blueprint to build foreign protein that would normally be produced by a pathogen or by a cancer cell. These protein molecules stimulate an adaptive immune response that teaches the body to identify and destroy the corresponding pathogen or cancer cells. The mRNA is delivered by a co-formulation of the RNA encapsulated in lipid nanoparticles that protect the RNA strands and help their absorption into the cells.
Also known as...
mRNA vaccine, mRNA-based vaccine, messenger RNA vaccine, mRNA vaccines, and RNA vaccines